Panel Discussion: Mobilizing Precision Cancer Care Through the Precision Cancer Consortium to Standardize Testing Pathways & Reduce Access Barriers
9:00 am - Thursday 8th October 2026
- How can multi‑company collaboration accelerate global access to comprehensive genomic profiling, particularly in regions where testing infrastructure and reimbursement remain limited?
- What operational barriers most constrain CGP adoption, and what tools can help standardize processes across health systems?
- How can harmonized testing pathways, shared training resources, and coordinated industry engagement reduce variation in CGP turnaround times and improve diagnostic quality globally?
